On December 30, 2021, Clindata Pharmaceutical Biotechnology (Beijing) Co., Ltd. joined the "Chinese Enterprise Brand Library", becoming the first clinical CRO in China to join the "Chinese Enterprise Brand Library". Clindata® will become your preferred clinical CRO.

       The Chinese enterprise brand library is an innovative practice under the new development stage, new development concept and new development pattern. It takes "enterprise" as the main body of service, and is the result of consensus, co-creation and sharing of all parties. It is the first enterprise brand library selected according to the national brand evaluation standard, and the first full-category co-construction with brand associations and industry organizations. Enterprise brand library, the first enterprise brand library to provide "brand finance" services.

       The Chinese enterprise brand library will connect with domestic and foreign high-level brand consulting, design, communication, asset evaluation, intellectual property, credit rating, investment institutions, etc., and provide services including brand training, consulting, design, and communication;  brand evaluation, evaluation, evaluation, Rating services; brand case-based, digital, chain-based, asset-based, international services; brand investment and financing, mergers and acquisitions, brand trust services, etc. Based on the information of Chinese enterprise brand library, it will provide brand credit information disclosure, brand award information disclosure, brand rating information disclosure, brand transfer, auction, merger and acquisition information disclosure, and brand bidding information disclosure.